Other OTC Pharmaceuticals (Pharmacies) - Eastern Europe

  • Eastern Europe
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$2.38bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.99%, resulting in a market volume of US$2.50bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$10.00 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Eastern Europe is experiencing steady growth and development due to several key factors.

Customer preferences:
Customers in Eastern Europe have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to various reasons, including the convenience of purchasing medications without a prescription, the increasing awareness and importance of self-care, and the affordability of OTC products compared to prescription medications. Additionally, customers in Eastern Europe tend to value the accessibility of pharmacies and the availability of a wide range of OTC products.

Trends in the market:
One significant trend in the Other OTC Pharmaceuticals (Pharmacies) market in Eastern Europe is the rising demand for vitamins, minerals, and supplements. Customers are becoming more health-conscious and are actively seeking ways to improve their overall well-being. As a result, there has been a surge in the consumption of dietary supplements, herbal remedies, and other health-enhancing products. This trend is driven by factors such as the aging population, increasing disposable income, and a growing interest in preventive healthcare. Another trend in the market is the growing popularity of natural and organic OTC products. Customers in Eastern Europe are increasingly inclined towards products that are perceived as natural, organic, and free from artificial ingredients. This shift in consumer preferences is driven by concerns about the potential side effects of synthetic medications and a desire for more sustainable and environmentally friendly options.

Local special circumstances:
Eastern Europe is a diverse region with varying healthcare systems and regulations. Some countries have more liberal regulations regarding the sale of OTC pharmaceuticals, allowing for a wider range of products to be available without a prescription. In contrast, other countries have stricter regulations, limiting the availability of certain OTC medications. These local regulations can influence the market dynamics and the types of products that are in demand in each country.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals (Pharmacies) market in Eastern Europe is also influenced by underlying macroeconomic factors. The region has witnessed steady economic growth, leading to an increase in disposable income and consumer spending power. As a result, customers have more financial resources to allocate towards healthcare and self-care products, including OTC pharmaceuticals. Additionally, the aging population in Eastern Europe is driving the demand for OTC products, as older individuals tend to require more medications and health-related products. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Eastern Europe is developing due to customer preferences for convenience, affordability, and accessibility. The market is experiencing trends such as the rising demand for vitamins and supplements, as well as the popularity of natural and organic products. Local regulations and varying healthcare systems also play a role in shaping the market dynamics. Overall, the growth of the market is supported by underlying macroeconomic factors, including economic growth and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)